Roche Australia have advised that availability of tocilizumab (Actemra) in Australia is improving but supply disruptions to some tocilizumab products will continue beyond January 2022.
The TGA regulates sunscreen products to ensure they meet the high standards for quality, safety and effectiveness set by the Australian regulatory guidelines for sunscreens.